H. M. , S. Júnior, D. F. Oliveira, D. A. De-carvalho, J. M. Pinto et al., Evaluation of native and exotic Brazilian plants for anticancer activity, J Nat Med, pp.64-231, 2010.

M. P. Decatris, S. Sundar, and K. J. O-'byrne, Platinum-based chemotherapy in metastatic breast cancer: current status, Cancer Treatment Reviews, vol.30, issue.1, pp.53-81, 2004.
DOI : 10.1016/S0305-7372(03)00139-7

A. M. Tsimberidou, F. Braiteh, D. J. Stewart, and R. Kurzrock, Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial, Journal of Clinical Oncology, vol.27, issue.36, pp.27-6243, 2009.
DOI : 10.1200/JCO.2009.23.6018

S. Dhar, N. Kolishetti, S. J. Lippard, and O. C. Farokhzad, Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo, Proceedings of the National Academy of Sciences, vol.108, issue.5, pp.1850-1855, 2011.
DOI : 10.1073/pnas.1011379108

L. F. Qin, T. K. Lee, and I. O. Ng, Gene expression profiling by cDNA array in human hepatoma cell line in response to cisplatin treatment, Life Sciences, vol.70, issue.14, pp.70-1677, 2002.
DOI : 10.1016/S0024-3205(01)01554-5

R. R. Siervo-sassi, A. M. Marrangoni, and X. Feng, Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines, Cancer Letters, vol.190, issue.1, pp.61-72, 2003.
DOI : 10.1016/S0304-3835(02)00579-7

M. Entezari, M. J. Mokhtari, and M. Hashemi, Evaluation of silibinin on the viability of MCF-7 human breast adenocarcinoma and HUVEC (Human Umbilical Vein Endothelial) cell lines, Advanced Studies in Biology, vol.3, pp.283-288, 2011.

H. M. Coley, Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer, Cancer Treatment Reviews, vol.34, issue.4, pp.378-390, 2008.
DOI : 10.1016/j.ctrv.2008.01.007

B. Rosenberg, L. Vancamp, and T. Krigas, Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode, Nature, vol.3, issue.4972, pp.205-698, 1965.
DOI : 10.1038/205698a0

R. Kim, M. Emi, and K. Tanabe, Role of mitochondria as the gardens of cell death, Cancer Chemotherapy and Pharmacology, vol.290, issue.5, pp.545-553, 2006.
DOI : 10.1007/s00280-005-0111-7

C. Sakakura, E. A. Sweeney, and T. Shirahama, Overexpression ofBax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide, Surgery Today, vol.55, issue.7, pp.676-679, 1997.
DOI : 10.1007/BF02388231

H. Thomadaki and A. Scorilas, Breast Cancer Cells Response to the Antineoplastic Agents Cisplatin, Carboplatin, and Doxorubicin at the mRNA Expression Levels of Distinct Apoptosis-Related Genes, Including the New Member, BCL2L12, Annals of the New York Academy of Sciences, vol.89, issue.1, pp.1095-1130, 2007.
DOI : 10.1016/0022-1759(83)90303-4